Current Atherosclerosis Reports

, Volume 13, Issue 1, pp 88–94

Lipid Effects of Endocrine Medications


DOI: 10.1007/s11883-010-0146-z

Cite this article as:
Mihailescu, D.V., Vora, A. & Mazzone, T. Curr Atheroscler Rep (2011) 13: 88. doi:10.1007/s11883-010-0146-z


Various alterations of lipid homeostasis have a significant role in the pathophysiology of the artherosclerotic process. The effects of usual lipid-lowering agents such as statins, fibrates, or niacin are well known, but other endocrine therapeutic agents could also affect the blood levels of various lipoproteins and, in turn, influence atheroma formation. In this review, we attempt to summarize the effect of several hormonal and non-hormonal endocrine agents on lipid metabolism, including insulin, thyroid hormone, sex hormones, glucocorticoids, growth hormone, and several anti-diabetic agents.


LipidsCardiovascularCholesterolLDLHDLInsulinGrowth hormoneThyroid hormoneTestosteroneEstrogen

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Dan V. Mihailescu
    • 1
  • Avni Vora
    • 1
  • Theodore Mazzone
    • 2
  1. 1.Department of MedicineUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Departments of Medicine, Pharmacology, and Kinesiology and NutritionUniversity of Illinois at ChicagoChicagoUSA